SEARCH

HOME / SEARCH / Tivantinib

iGMDRD444

Canonical SMILES: C1CC2=CC=CC3=C2N(C1)C=C3C4C(C(=O)NC4=O)C5=CNC6=CC=CC=C65

InChI: InChI=1S/C23H19N3O2/c27-22-19(16-11-24-18-9-2-1-7-14(16)18)20(23(28)25-22)17-12-26-10-4-6-13-5-3-8-15(17)21(13)26/h1-3,5,7-9,11-12,19-20,24H,4,6,10H2,(H,25,27,28)/t19-,20-/m0/s1

InChI Key: UCEQXRCJXIVODC-PMACEKPBSA-N

Loading, please wait...

Standard Name	CHEMBL	Pubchem CID	DRUGBANK ID	Drug Status	Drug Type
Standard NameTivantinib CHEMBLCHEMBL2103882 Pubchem CID11494400 DRUGBANK IDDB12200 Drug StatusAlone Drug TypeSmall Molecule

Drug Class:

Heterocyclic Compounds Heterocyclic Compounds, 1-Ring Heterocyclic Compounds, 2-Ring Proto-Oncogene Proteins c-met, antagonists & inhibitors Pyrrolidines

Drug Targets:

MET (P08581)FLT1 FLT3 KDR

Drug Pathways:

RTK signaling

Drug-model tissue-cancer distribution: Bubble Plot

Drug-gene pathway enrichments

Drug-gene GO enrichments

Drug-Gene: Aster Plot

Loading, please wait...

Gene ID	Gene Name	Model Num.
132	ADK	3
4926	NUMA1	2
23513	SCRIB	3
2956	MSH6	1

Showing 1 to 4 of 64 rows rows per page

Gene in drug-gene network: Network Plot

Models in Tivantinib

Loading, please wait...

	Model	Level	Reference ID	Tissue	Cancer	Drug	Clinical Response	Source
No matching records found

SITE

DATATYPES

CLASSFICATION

Disclaimer: iGMDR is intended for research purposes only. Its information cannot be used for emergencies or medical or professional advice.